1. Le grand livre des soins palliatifs
  2. Dyspnée et détresses en soins palliatifs [Tome II Chapitre V]

Lectures

  1. Christine Brooker, De Boeck Supérieur, Le corps humain: Étude, structure et fonction, 2001 p. 282.

  2. Dr Sitbon, Pr Brambilla, Pr Pison, Dr Burgel, Dyspnées aiguës et dyspnées chroniques, Collège des enseignants de pneumologie, mise à jour 2010.

  3. Dr Gérard Pralong, Dr Frederic Fellrath, Guide des soins palliatifs du médecin vaudois; no 10, 2009.

  4. Patrick Vinay, Luc Belleau, Michelle Dallaire, Serge Daneault, Geneviève Dequoy, Louise Gagnon, Lucie Laplante, Marie-Frédérique Thibault, Soigner les râles terminaux, Médecine   palliative — Soins de support — Accompagnement — Éthique (2010) 9, 148-156.

  5. Guy Frenette MD,  André-Didier Barbant MD, La dyspnée et la détresse respiratoire en soins palliatifs, Maison Victor Gadbois, 2005.

  6. Thomas JR, von Gunten CF, Clinical management of dyspnoea. Lancet Oncol 2002;3(4):223-8.

  7. Boyd KJ, Kelly M, Oral morphine as symptomatic treatment of dyspnoea in patients with advanced cancer. Palliat Med 1997;11(4):277-81.

  8. Bruera E, Macmillan K, Pither J, MacDonald RN, Effects of morphine on the dyspnoea of terminal cancer patients. J Pain Symptom Manage 1990;5(6):341-4.

  9. Estfan B, Mahmoud F,  Shaheen P, Davis MP, Lasheen W, Rivera N, et al. Respiratory function during parenteral opioid titration for cancer pain. Palliat Med 2007;21(2):81-6.

  10. Ko S, Goldstein DH, VanDenKerkhof EG, Definitions of “respiratory depression” with intrathecal morphine postoperative analgesia: a review of the literature. Can J Anaesth 2003;50(7): 679-88.

  11. Clemens KE, Klaschik E,  Symptomatic therapy of dyspnea with strong opioids and its effect on ventilation in palliative care patients. J Pain Symptom Manage 2007;33(4):473-81.

  12. Romayne Gallagher, Éliminer les symptômes sans éliminer le patient. Canadian Family Physician June 2010 vol. 56 no. 6 e210-e212.

  13. Jennings AL, Davies AN, Higgins JPT, et al. A systematic review of the use of opioids in the management of dyspnea. Thorax 2002; 57:939-44.

  14. Boyd KJ, Kelly M, Oral morphine as symptomatic treatment of dyspnoea in patients with advanced cancer. Palliat Med 1997;11(4):277-81.

  15. Chan JD, Treece PD,  Engelberg RA, Crowley L, Rubenfeld GD, Steinberg KP, et al.  Narcotic and benzodiazepine use after withdrawal of life support: association with time of death? Chest 2004;126(1):286-93.

  16. Simon ST, Higginson IJ, Booth S, Harding R, Bausewein C, Benzodiazepines for the relief of breathlessness in advanced diseases in adults, Revue de Cochrane Mars 2011.

  17. Bennett M, Lucas V, Brennan M, Hughes A, O'Donnell V, Wee B. Using anti-muscarinic drugs in the management of death rattle: evidence-based guidelines for palliative care. Palliative Medicine. 2002; 16(5): 369-374.

  18. Lokker ME, van Zuylen L, van der Rijt CC, van der Heide A. Prevalence, impact, and treatment of death rattle: a systematic review. J Pain Symptom Management 2013.

  19. Interventions to treat noisy breathing, or 'death rattle': the unpleasant, gurgling breathing occurring in many patients who are about to die. In: Cochrane Database of Systematic Reviews; 2012. http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0013298/

  20. Wildiers H, Dhaenekint C, Demeulenaere P, et al. Atropine, Hyoscine butylbromide, or scopolamine are equally effective for the treatment of death rattle in terminal care. J Pain Symptom Manage. 2009;38(1):124-133.

  21. Clark K, Currow DC, Agar M, Fazekas BS, Abernethy AP. A pilot phase II randomized, crossover, double-blinded, controlled efficacy study of octreotide versus hyoscine hydrobromide for control of noisy breathing at the end-of-life. J Pain Palliat Care Pharmacother.   2008;   22(2): pp131-138.

  22. Abernethy AP, McDonald CF, Frith PA, et al. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnea: a double-blind, randomized controlled trial. Lancet. 2013;376(9743):734-93.

  23. Campbell ML, Templin T, Walch J. A respiratory distress observation scale for patients unable to self-report dyspnea. J Palliat Med. 2010;13(3):285-90. - See more at: http://www.rtmagazine.com/2013/06/end-of-life-oxygen-therapy-2/#sthash.nHOqAlF8.dpuf

  24. Raymond Viola, Cathy Kiteley, Nancy S. Lloyd, Jean A. Mackay , Julie Wilson, Rebecca K. S. Wong, The management of dyspnea in cancer patients: a systematic review, Supportive Care in Cancer; April 2008, Volume 16, Issue 4, pp 329-337.

  25. Néron Andrée et al., Guide pratique des soins palliatifs, gestion de la douleur et autres symptômes, Association des pharmaciens des établissements de santé ayant un intérêt pour les soins palliatifs, 4e édition complète 2008, p. 229-231.

  26. Gouvernement du Québec, LOI CONCERNANT LES SOINS DE FIN DE VIE, chapitre S-32.0001.

  27. RECOMMANDATIONS QUÉBÉCOISES POUR LA PRATIQUE DE LA SÉDATION PALLIATIVE
    Proposées par la Société québécoise des médecins de soins palliatifs
    http://www.palli-science.com/recommandations-quebecoises-pour-la-pratique-de-la-sedation-palliative; 1 novembre 2014.